Pharos Capital Group (Pharos), a middle-market private equity firm based in Dallas and Nashville, has made a significant investment in Renal Care 360°, a comprehensive nephrology practice and chronic care management company founded by Joe Cashia.
Renal Care 360° partners with health systems, physician groups and local communities to provide enhanced community healthcare management services with a primary focus on patients in underserved, rural communities.
Pharos’s investment, along with additional equity investment from the Company’s founding shareholders, will be used to support continued growth of the Company’s RC360° Connected Care Program, geographic expansion through acquisitions, and development of value-based care programs. Terms of the transaction were not disclosed.
Renal Care 360° has developed a unique model centred on early detection of unidentified chronic conditions using proprietary data analytics. Once medical conditions are identified, the Company offers early interventions through its affiliated physician practices with personalised education, real-time engagement, local and virtual clinic options, and dedicated care coordination to slow disease progression and improve outcomes for chronic kidney disease (CKD), end stage kidney disease (ESKD), and other co-morbidities. Renal Care 360° is also raising awareness and improving education of kidney disease in areas most impacted by inequities in access to care, enabling its health system and physician group partners to proactively engage and care for their patients.
Renal Care 360° founder Joe Cashia will continue to lead the Company as Chairman and CEO. Cashia is a 35-plus-year veteran of the healthcare industry with deep experience across the continuum of kidney care who has partnered with physicians and hospitals across the country and has created, acquired, and managed more than 1,000 healthcare centres. Previously serving as CEO of National Renal Alliance, Vivere Health, and Ascend Health Care Services and in various Board roles, Cashia has extensive experience in scaling complex healthcare service organisations with a deep appreciation for the importance of partnering with physician leaders and clinicians to drive value-based care initiatives and improve patient outcomes.
Cashia says: “We are pleased to bring in such an experienced, healthcare-focused partner to help Renal Care 360° rapidly expand its care model to touch the lives of as many patients as possible. Pharos’s dedication to bridging inequities in care, demonstrated by their proven track record guiding value-based healthcare organisations, will be invaluable as we grow our clinic footprint, scale chronic care management infrastructure to meet the overwhelming market need, and work with health systems and payors to align incentives around optimisation of patient outcomes to generate transformational cost savings to the system.”
This marks the fourth investment from Pharos’s latest flagship fund, Pharos Capital Partners IV, L.P., investing alongside its parallel fund, Pharos Capital Partners IV-A, L.P., a licensed Rural Business Investment Company. The funds will continue Pharos’s mission of lowering costs, improving outcomes, and expanding access to care, particularly within underserved rural communities.
